Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005059032 | SCV003031837 | pathogenic | Ichthyosis linearis circumflexa | 2024-06-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys824Argfs*99) in the SPINK5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPINK5 are known to be pathogenic (PMID: 11511292, 11841556). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Netherton syndrome (PMID: 32533806). This variant is also known as chr5:147499882_147499885delAAAG (p.Lys824ArgfsTer117). For these reasons, this variant has been classified as Pathogenic. |
3billion | RCV002776177 | SCV004013506 | pathogenic | Netherton syndrome | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. The variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with SPINK5 related disorder (PMID: 32533806). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. | |
Gene |
RCV004721087 | SCV005327800 | pathogenic | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32533806) |